302 related articles for article (PubMed ID: 31186067)
21. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
[TBL] [Abstract][Full Text] [Related]
22. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
[TBL] [Abstract][Full Text] [Related]
23. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.
Holt N; Wang J; Kim K; Friedman G; Wang X; Taupin V; Crooks GM; Kohn DB; Gregory PD; Holmes MC; Cannon PM
Nat Biotechnol; 2010 Aug; 28(8):839-47. PubMed ID: 20601939
[TBL] [Abstract][Full Text] [Related]
24. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
[TBL] [Abstract][Full Text] [Related]
25. Improved Cas9 activity by specific modifications of the tracrRNA.
Scott T; Urak R; Soemardy C; Morris KV
Sci Rep; 2019 Nov; 9(1):16104. PubMed ID: 31695072
[TBL] [Abstract][Full Text] [Related]
26. PlmCas12e (CasX2) cleavage of CCR5: impact of guide RNA spacer length and PAM sequence on cleavage activity.
Armstrong DA; Hudson TR; Hodge CA; Hampton TH; Howell AL; Hayden MS
RNA Biol; 2023 Jan; 20(1):296-305. PubMed ID: 37287312
[TBL] [Abstract][Full Text] [Related]
27. Efficient Production of Gene-Modified Mice using Staphylococcus aureus Cas9.
Zhang X; Liang P; Ding C; Zhang Z; Zhou J; Xie X; Huang R; Sun Y; Sun H; Zhang J; Xu Y; Songyang Z; Huang J
Sci Rep; 2016 Sep; 6():32565. PubMed ID: 27586692
[TBL] [Abstract][Full Text] [Related]
28. A mathematical model of HIV dynamics treated with a population of gene-edited haematopoietic progenitor cells exhibiting threshold phenomenon.
Ratti V; Nanda S; Eszterhas SK; Howell AL; Wallace DI
Math Med Biol; 2020 May; 37(2):212-242. PubMed ID: 31265056
[TBL] [Abstract][Full Text] [Related]
29. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9.
Mandal PK; Ferreira LM; Collins R; Meissner TB; Boutwell CL; Friesen M; Vrbanac V; Garrison BS; Stortchevoi A; Bryder D; Musunuru K; Brand H; Tager AM; Allen TM; Talkowski ME; Rossi DJ; Cowan CA
Cell Stem Cell; 2014 Nov; 15(5):643-52. PubMed ID: 25517468
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo.
Sato K; Misawa N; Iwami S; Satou Y; Matsuoka M; Ishizaka Y; Ito M; Aihara K; An DS; Koyanagi Y
PLoS Pathog; 2013; 9(12):e1003812. PubMed ID: 24339781
[TBL] [Abstract][Full Text] [Related]
31. Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells.
Yudovich D; Bäckström A; Schmiderer L; Žemaitis K; Subramaniam A; Larsson J
Sci Rep; 2020 Dec; 10(1):22393. PubMed ID: 33372184
[TBL] [Abstract][Full Text] [Related]
32. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
33. Highly specific targeted mutagenesis in plants using Staphylococcus aureus Cas9.
Kaya H; Mikami M; Endo A; Endo M; Toki S
Sci Rep; 2016 May; 6():26871. PubMed ID: 27226350
[TBL] [Abstract][Full Text] [Related]
34. Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.
Li L; Krymskaya L; Wang J; Henley J; Rao A; Cao LF; Tran CA; Torres-Coronado M; Gardner A; Gonzalez N; Kim K; Liu PQ; Hofer U; Lopez E; Gregory PD; Liu Q; Holmes MC; Cannon PM; Zaia JA; DiGiusto DL
Mol Ther; 2013 Jun; 21(6):1259-69. PubMed ID: 23587921
[TBL] [Abstract][Full Text] [Related]
35. Inducing CCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+ Cell Line and Primary CD4+ Cells by CRISPR-Cas9 Genome-Editing Technology.
Qi C; Li D; Jiang X; Jia X; Lu L; Wang Y; Sun J; Shao Y; Wei M
Mol Ther Nucleic Acids; 2018 Sep; 12():267-274. PubMed ID: 30195765
[TBL] [Abstract][Full Text] [Related]
36. AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.
Li A; Tanner MR; Lee CM; Hurley AE; De Giorgi M; Jarrett KE; Davis TH; Doerfler AM; Bao G; Beeton C; Lagor WR
Mol Ther; 2020 Jun; 28(6):1432-1441. PubMed ID: 32348718
[TBL] [Abstract][Full Text] [Related]
37. Biallelic, Selectable, Knock-in Targeting of CCR5
Scheller SH; Rashad Y; Saleh FM; Willingham KA; Reilich A; Lin D; Izadpanah R; Alt EU; Braun SE
Front Immunol; 2022; 13():821190. PubMed ID: 35386712
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infection.
Tsukamoto T
AIDS; 2018 Aug; 32(13):1737-1747. PubMed ID: 29762163
[TBL] [Abstract][Full Text] [Related]
39. Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cells.
Ting PY; Parker AE; Lee JS; Trussell C; Sharif O; Luna F; Federe G; Barnes SW; Walker JR; Vance J; Gao MY; Klock HE; Clarkson S; Russ C; Miraglia LJ; Cooke MP; Boitano AE; McNamara P; Lamb J; Schmedt C; Snead JL
Nat Methods; 2018 Nov; 15(11):941-946. PubMed ID: 30297964
[TBL] [Abstract][Full Text] [Related]
40. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
